Provided by Tiger Trade Technology Pte. Ltd.

T. Rowe Price Health Care ETF

35.89
+0.47161.33%
Post-market: 35.970.0753+0.21%19:30 EDT
Volume:18.95K
Turnover:679.54K
Market Cap:31.41M
PE:- -
High:35.97
Open:35.42
Low:35.42
Close:35.42
52wk High:36.72
52wk Low:24.99
Shares:875.00K
Float Shares:875.00K
Volume Ratio:1.88
T/O Rate:2.17%
Dividend:0.16
Dividend Rate:0.45%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit

Reuters
·
Aug 22

UnitedHealth Group (UNH) Stock Looks Cheap On Value But Faces Risk On News

Simply Wall St.
·
Aug 22

Eli Lilly Targets Ramadan Diabetes Market With New Orforglipron Trial

TIPRANKS
·
Aug 22

Eli Lilly’s Dulaglutide Study Sheds Light on Fasting Risks and Diabetes Care

TIPRANKS
·
Aug 22

Dow Jones Top Company Headlines at 9 am ET: Nvidia in Talks to Invest in Data-Center Power Developer Cloverleaf | Italy's ...

Dow Jones
·
Aug 21

Pharma Stocks Have Rallied. 2 Stocks to Avoid-and 2 to Buy.

Dow Jones
·
Aug 21

Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT), Alvotech (ALVO) and Abbott Laboratories (ABT)

TIPRANKS
·
Aug 21

William O'Neil Initiates Thermo Fisher Scientific at Buy

MT Newswires Live
·
Aug 21

Analysts Have Conflicting Sentiments on These Healthcare Companies: Abbott Laboratories (ABT) and Doximity (DOCS)

TIPRANKS
·
Aug 21

PRESS Digest-Wall Street Journal - August 21

Reuters
·
Aug 21

Abbott : TD Cowen Raises Target Price to $135 from $115

THOMSON REUTERS
·
Aug 21

Perrigo Co. PLC Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 21

Gilead (GILD) Stock Still Looks Below Fair Value As Court Backs HIV Import Block

Simply Wall St.
·
Aug 21

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 21

Moderna Inc. Stock Slips 23.5%, Underperforms Peers

Dow Jones
·
Aug 21

Abbott Reaches Agreements to Resolve Portion of Litigation over Infant Formula

Reuters
·
Aug 21

Abbott resolves portion of litigation regarding specialty infant formulas

TIPRANKS
·
Aug 21

Abbott Agrees to Settle Preterm Infant Formula NEC Lawsuits for About $670 Million

Reuters
·
Aug 21

Abbott Reaches Agreements to Resolve a Portion of Litigation Involving Its Specialty Formulas for Preterm Infants

THOMSON REUTERS
·
Aug 21

Abbott - to Pay About $670 Mln to Resolve Gill Case and Nec Claims

THOMSON REUTERS
·
Aug 21